1. Drug Enforcement Administration/Department of Justice, (2014) Data Review Document: Eight Factor Analysis for 4-methyl-N-ethylcathinone (4-MEC), 4-methyl-pyrrolidino-propiophenone (4-MePPP), alpha-pyrrolidinopentiophenone (α-PVP), 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one (butylone), 2-(methylamino)-1-phenylpentan-1-one (pentedrone), 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one (pentylone), 4-fluoro-N-methylcathinone (4-FMC; flephedrone), 3-fluoro-N-methylcathinone (3-FMC), 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one (naphyrone), alpha-pyrrolidinobutiophenone (α-PBP). Submitted to Dr. Karen DeSalvo, Acting Assistant Secretary for Health, Department of Health and Human Services
2. AAPCC (2013) American Association of Poison Control Centers. Bath salts data
3. AAPCC (2014) American Association of Poison Control Centers. 2014. Bath salts data
4. Aarde SM, Creehan KM, Vandewater SA, Dickerson TJ, Taffe MA (2015) In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats. Psychopharmacology 232(16):3045–3055
5. Balster RL, Bigelow GE (2003) Guidelines and methodological reviews concerning drug abuse liability assessment. Drug Alcohol Depend 70:S13–S40